Case of ketoacidosis by a sodium-glucose cotransporter 2 inhibitor in a diabetic patient with a low-carbohydrate diet

被引：82

作者：

Hayami, Tomohide ^{[1
]}

Kato, Yoshiro ^{[1
]}

Kamiya, Hideki ^{[1
]}

Kondo, Masaki ^{[1
]}

Naito, Ena ^{[1
]}

Sugiura, Yukako ^{[1
]}

Kojima, Chika ^{[1
]}

Sato, Sami ^{[1
]}

Yamada, Yuichiro ^{[1
]}

Kasagi, Rina ^{[1
]}

Ando, Toshihito ^{[1
]}

Noda, Saeko ^{[1
]}

Nakai, Hiromi ^{[1
]}

Takada, Eriko ^{[1
]}

Asano, Emi ^{[1
]}

Motegi, Mikio ^{[1
]}

Watarai, Atsuko ^{[2
]}

Kato, Koichi ^{[3
]}

Nakamura, Jiro ^{[1
]}

机构：

[1] Aichi Med Univ, Sch Med, Dept Internal Med, Div Diabet, Nagakute, Aichi 48011, Japan

[2] Chubu Rosai Hosp, Ctr Prevent Med, Nagoya, Aichi, Japan

[3] Aichi Gakuin Univ, Sch Pharm, Lab Med, Nagoya, Aichi 464, Japan

来源：

JOURNAL OF DIABETES INVESTIGATION | 2015年 / 6卷 / 05期

关键词：

Ketoacidosis; Low-carbohydrate diet; Sodium-glucose cotransporter2 inhibitor; INSULIN SENSITIVITY; DAPAGLIFLOZIN;

D O I：

10.1111/jdi.12330

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We present a case of a 32-year-old diabetic woman with Prader-Willi syndrome who developed severe ketoacidosis caused by a sodium-glucose cotransporter2 (SGLT2) inhibitor, a novel class of antihyperglycemic agents, during a strict low-carbohydrate diet. At admission, a serum glucose level of 191mg/dL was relatively low, though laboratory evaluations showed severe ketoacidosis. This is the first report of ketoacidosis caused by a SGLT2 inhibitor. It is necessary to not only pay attention when using a SGLT2 inhibitor in patients following a low-carbohydrate diet, but also to start a low-carbohydrate diet in patients treated with a SGLT2 inhibitor because of a high risk for developing ketoacidosis.

引用

页码：587 / 590

页数：4

共 50 条

[21] Sodium-glucose cotransporter 2 inhibitor-induced euglycemic diabetic ketoacidosis in a patient with coronavirus disease 2019: a case report
Yii, Edwin Sze Sian
Azli, Athirah Wan
Sitaram, Premela Naidu
JOURNAL OF MEDICAL CASE REPORTS, 2022, 16 (01)
[22] CHALLENGES IN THE DIAGNOSIS OF EUGLYCEMIC DIABETIC KETOACIDOSIS IN A PATIENT WITH MULTIPLE SCLEROSIS TAKING A SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITOR
Allison, Robert
Goldstein, Daniel
Musso, Mandi W.
JOURNAL OF EMERGENCY MEDICINE, 2019, 57 (01): : E1 - E3
[23] Euglycemic diabetic ketoacidosis induced by sodium-glucose cotransporter 2 inhibitor in the setting of prolonged fasting: a case report
Alkatheeri, Abrar
Alseddeeqi, Eiman
JOURNAL OF MEDICAL CASE REPORTS, 2022, 16 (01)
[24] Intraoperative Diagnosis of Sodium-Glucose Cotransporter 2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis: A Case Report
Seger, Christian D.
Xing, Hanning
Wang, Libing
Shin, John S.
A & A PRACTICE, 2021, 15 (01): : e01380
[25] Euglycemic diabetic ketoacidosis induced by sodium-glucose cotransporter 2 inhibitor in the setting of prolonged fasting: a case report
Abrar Alkatheeri
Eiman Alseddeeqi
Journal of Medical Case Reports, 16
[26] Sodium-Glucose Cotransporter 2 Inhibitor-Associated "Ketoacidosis" Versus "Diabetic Ketoacidosis": The Importance of Accurate Terminology
Milder, Tamara Y.
Milder, David A.
Greenfield, Jerry R.
Day, Richard O.
DRUG SAFETY, 2023, 46 (12) : 1303 - 1305
[27] Prolonged euglycemic diabetic ketoacidosis triggered by a single dose of sodium-glucose cotransporter 2 inhibitor
Miwa, Maki
Nakajima, Mikio
Kaszynski, Richard H.
Goto, Hideaki
BMJ CASE REPORTS, 2020, 13 (10)
[28] Sodium-Glucose Cotransporter 2 Inhibitor-Associated “Ketoacidosis” Versus “Diabetic Ketoacidosis”: The Importance of Accurate Terminology
Tamara Y. Milder
David A. Milder
Jerry R. Greenfield
Richard O. Day
Drug Safety, 2023, 46 : 1303 - 1305
[29] Diabetic Ketoacidosis With Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, in Patients With Type 1 Diabetes
Peters, Anne L.
Henry, Robert R.
Thakkar, Payal
Tong, Cindy
Alba, Maria
DIABETES CARE, 2016, 39 (04) : 532 - 538
[30] Euglycemic Diabetic Ketoacidosis Secondary to Sodium-Glucose Cotransporter 2 Inhibitors
Khaliq, M. F.
Mohamed, H. E.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199

← 1 2 3 4 5 →